This is a cracking announcement, not that it will gain much traction in current market.
Pre-clinical mouse model showing greater effectiveness from AD-214 as compared to the 2 drugs currently in the market for IPF.
Still on track for mid-year first patient dosing in the phase 1 trial.
It's a happy buy and wait for me
Ann: AD-214 effective in gold standard pre-clinical animal model, page-2
Add 1AD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.3¢ |
Change
-0.001(4.17%) |
Mkt cap ! $12.26M | |||
| Open | High | Low | Value | Volume |
| 2.5¢ | 2.5¢ | 2.3¢ | $2.466K | 102.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 635388 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 302763 | 4 |
View Market Depth
| Last trade - 15.02pm 15/05/2024 (20 minute delay) ? |
| 1AD (ASX) Chart |